RUXIENCE

This brand name is authorized in United States. It is also authorized in Austria, Brazil, Canada, Croatia, Estonia, Finland, France, Ireland, Israel, Italy, Lithuania, Netherlands, New Zealand, Poland, Romania, Spain, Turkey, UK.

Active ingredients

The drug RUXIENCE contains one active pharmaceutical ingredient (API):

1	Rituximab UNII 4F4X42SYQ6 - RITUXIMAB
	Rituximab binds specifically to the transmembrane antigen, CD20, a non-glycosylated phosphoprotein, located on pre-B and mature B lymphocytes. The antigen is expressed on >95% of all B cell non-Hodgkin’s lymphomas.
	Read more about Rituximab

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
RUXIENCE Concentrate for solution for infusion	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L01FA01	Rituximab	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01F Monoclonal antibodies and antibody drug conjugates → L01FA CD20 (Clusters of Differentiation 20) inhibitors
Discover more medicines within L01FA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	522720090089607, 522720090089707
CA	Health Products and Food Branch	02495724
EE	Ravimiamet	1815522, 1815533
ES	Centro de información online de medicamentos de la AEMPS	1201431001, 1201431002
FI	Lääkealan turvallisuus- ja kehittämiskeskus	555963, 566176
FR	Base de données publique des médicaments	66217549, 67613747
GB	Medicines & Healthcare Products Regulatory Agency	385891, 385919
IL	מִשְׂרַד הַבְּרִיאוּת	9093, 9094
IT	Agenzia del Farmaco	048720015, 048720027
LT	Valstybinė vaistų kontrolės tarnyba	1089842, 1089843
NL	Z-Index G-Standaard, PRK	51004, 51012
NZ	Medicines and Medical Devices Safety Authority	21533, 21534
PL	Rejestru Produktów Leczniczych	100439201, 100439218
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W66628001, W66629001
TR	İlaç ve Tıbbi Cihaz Kurumu	8681308771032, 8681308771049
US	FDA, National Drug Code	0069-0238, 0069-0249